Tarmed

Quick links to important sections

Tarmed

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tarmed

Quick Facts

Property Description
Active ingredient Charcoal, Activated (Carbo activatus)
Pharmacological class Adsorbent, Gastric Decontamination Agent
Route of administration Oral
Origin Derived (from carbonaceous material)
Available forms Aqueous suspension, Tablet, Capsule, Powder

Tarmed, containing the active ingredient Charcoal, Activated (INN), is utilized to bind and clear various substances from the gastrointestinal tract. Activated charcoal is widely recognized for its inclusion on lists of essential medicines for managing acute oral poisoning emergencies.


What Type of Medicine is Tarmed (Activated Charcoal)?

Tarmed is fundamentally a non-systemic medicine because its action is localized entirely to the digestive system, meaning the substance itself is not absorbed into the bloodstream. The active ingredient, Charcoal, Activated, is categorized as an Adsorbent, a pharmacological class defined by its ability to physically bind molecules to its surface. This mechanism is utilized for its effectiveness in reducing the overall toxic load following the ingestion of certain substances.

The general therapeutic purpose of this drug is to limit the systemic absorption of toxins, poisons, or drug excesses from the gastrointestinal tract. The use of activated charcoal is intended to reduce the availability of various agents to the body by preventing absorption from the gut. This describes the medicine's role in minimizing systemic exposure.


Composition, Origin, and Available Forms

The Activated charcoal active ingredient is a carbon-rich material created through a specialized, high-temperature activation process. This process yields fine black porous granules with an exceptionally high internal surface area. Tarmed is a single-ingredient product delivered via the oral route.

The medicine is most commonly prepared for patient use as an aqueous suspension (or slurry), though it is also available in solid dosage forms like tablets or capsules. The formulation is designed to ensure that the equivalent of one gram of activated charcoal meets specific adsorption standards.


The Core Physical Action of an Adsorbent

The general benefit is achieved through the physical action known as adsorption, where the high-surface-area material traps toxins on its surface. This process prevents the substances from being transferred across the intestinal lining and into the body’s systemic circulation. The physical trapping mechanism is a standard approach in managing certain ingestions.

The non-systemic nature of the drug means that the bound complexes of charcoal and toxin remain inert. They are subsequently eliminated entirely via excretion in feces, thereby interrupting potential biological recirculation processes.

Regulatory References

  1. WHO Essential Medicines Lists
  2. Activated charcoal entry on WHO's EML

What side effects are possible with Tarmed?

Possible Side Effects and Safety Information

The safety profile for Tarmed (Activated Charcoal) is based on its non-systemic action, meaning the documented adverse reactions are primarily confined to the gastrointestinal tract and administration risks, as outlined in official regulatory documents.

Gastrointestinal Adverse Reactions and Frequency

Adverse effects commonly associated with the passage of the inert carbon material through the digestive system are classified as common in official labeling:

  • Faecal discolouration (black stools)
  • Constipation

Nausea and vomiting have also been reported. Products containing a cathartic agent may also cause severe cramping and diarrhea, which can lead to significant fluid and electrolyte abnormalities.

Serious Adverse Reactions

The regulatory safety documents highlight specific, serious concerns, typically listed with an undefined frequency:

  • Pulmonary Aspiration: The most serious safety risk is the potential for the charcoal suspension to enter the lungs (aspiration pneumonitis), a complication primarily linked to the patient's level of consciousness during administration.
  • Gastrointestinal Obstruction: Ileus or intestinal obstruction has been documented, with the risk noted to increase with multiple-dose therapy or pre-existing low bowel motility.

Safety Restrictions and Considerations

The adsorbent nature of the medicine imposes several high-level safety constraints:

  • Reduced Absorption: Tarmed can decrease the systemic availability and therapeutic effect of other oral medications taken concurrently.
  • Population Specificity: Due to the risk of severe fluid imbalance, the use of cathartics in co-formulated products is restricted in young children.
  • Substance Limitations: The medicine is officially documented as ineffective or contraindicated for specific ingested substances, such as iron, lithium, petroleum products, or corrosive agents.

Overdose and Emergency Response

Overdose manifestations for Activated Charcoal are defined by regulatory authorities as primarily non-systemic, focusing on local complications rather than toxicity from the adsorbent itself. Documented presentations of over-administration include gastrointestinal effects such as constipation and abdominal distension. A severe, life-threatening outcome that may follow massive doses or repeated use is intestinal obstruction (or gastrointestinal blockage).

A second major risk highlighted in regulatory labeling is pulmonary aspiration, which can lead to the severe complication of aspiration pneumonitis. This risk is specifically elevated in high-risk patients, including those with impaired consciousness or pre-existing conditions like intestinal hypomotility.

When symptoms such as severe abdominal pain, difficulty breathing, or signs suggestive of blockage occur, regulatory documents mandate that individuals seek immediate medical attention or contact a poison control center. No specific antidote is known for charcoal-induced toxicity; therefore, management is limited to providing symptomatic and supportive treatment. Hospital monitoring may be required for patients presenting with these severe manifestations.

Therapeutic Uses of Tarmed

What Tarmed Treats: Main Uses and Benefits

Tarmed, containing Activated Charcoal, is commonly used to provide symptomatic support during acute events. Its use is relevant for easing symptoms related to systemic imbalance by assisting in the management of ingested toxins and certain drug excesses, which may help to reduce the overall burden of systemic exposure. Activated charcoal is recognized as a non-specific agent for acute intoxication management in clinical settings.

The medication is applied in addressing conditions characterized by periods of heightened symptoms following acute oral poisoning and drug overdose. It is commonly used in conditions that present with acute episodes due to ingestions of agents like salicylates, acetaminophen, and certain sedatives.

“Tarmed is commonly used to provide supportive relief when acute manifestations interfere with function due to the substance entering the body's circulation.”


Quick Fact: Support for Symptoms related to Systemic Imbalance

Condition Category Symptom Management Role Key Benefit Provided
Acute Poisoning Addresses systemic imbalance Contributes to improved comfort by reducing exposure
Drug Overdose Supports against systemic toxicity manifestations Assists with supporting the patient during difficult episodes
Recirculating Toxins Helps enhance elimination Supports the patient during difficult episodes

Regulatory References

  1. WHO Essential Medicines List

Eligibility and Restrictions for Use

The eligibility for Tarmed (Activated Charcoal) is strictly defined by official regulatory guidelines, focusing on the patient's airway and the gastrointestinal system, and the efficacy of the medicine against the ingested substance.

Populations for Whom Use is Contraindicated

Use is prohibited for individuals with an unprotected airway (i.e., a depressed level of consciousness who are not intubated) due to the severe risk of pulmonary aspiration. It is also contraindicated in patients with, or at risk of, intestinal obstruction or gastrointestinal perforation.

Furthermore, the medicine must not be used following the ingestion of substances it does not effectively adsorb. These efficacy-based contraindications include corrosive agents (acids/alkalis), petroleum distillates (hydrocarbons), and certain metals like iron and lithium.

Age and Reproductive Eligibility

Tarmed is permitted for use across all age groups (infants through older adults) and is allowed during pregnancy and lactation. This is due to its non-systemic action; the medicine is not absorbed into the bloodstream, and no specific restrictions are documented for patients with hepatic or renal impairment.

Eligibility-Related Restrictions

Official labeling advises caution in patients with conditions causing decreased peristalsis (slowed bowel movement). Formulations containing a cathartic like sorbitol are not recommended for repeated administration or for use in infants.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medicine's topical regulatory profile is mainly defined by the risk of augmented photosensitivity due to the coal tar component. As such, official regulatory documents indicate caution is necessary when this product is used concurrently with other medicinal products known to be photosensitizers. The mechanistic basis of this interaction is the additive effect on sensitivity to sunlight or UV exposure.

Interacting Products and Product Classes

Category or Class Specific Examples (Regulatory Examples) Interaction Relevance
Photosensitizers Thiazides, Tetracyclines, Fluoroquinolones, Phenothiazines, Sulfonamides Use with Caution (Additive Risk)

Interaction-Related Restrictions

Regulatory cautions specify that the product should be used with prudence when co-administered with other photosensitising drugs because of the increased possibility of augmented photosensitivity reactions. Since Tarmed is a topical product with minimal systemic absorption, the risk of significant pharmacokinetic interactions with most other systemic medicines is generally considered low or absent, and no other high-level interaction classifications (e.g., contraindications) are typically noted in the official labeling. Always inform a healthcare professional of all current medicines, including over-the-counter and herbal products.

Mechanism of Action

Tarmed's mechanism is non-systemic, relying on a unique physico-chemical process rather than biological signaling pathways, enzymes, or receptors. Its action is entirely contained within the digestive tract.

Physical Trapping Mechanism (Adsorption)

This domain covers the core molecular interaction: the charcoal's high internal surface area acts as a non-biological adsorbent to physically bind (adsorb) external molecules. This binding occurs via weak, non-covalent forces, such as Van der Waals interactions, which stabilize the toxins onto the porous carbon structure. This is a purely physical mechanism that rapidly isolates the targeted substance from the surrounding digestive fluid.

Disruption of Systemic Absorption

The stable charcoal-toxin complex formed in the gut lumen disrupts the transfer process across the intestinal mucosa. The complex remains confined to the gut lumen, thereby limiting the fraction of the substance that enters the systemic circulation. This mechanism also interferes with the enterohepatic recirculation of compounds that have been secreted back into the gut, promoting complete and irreversible excretion in feces, which results in a reduction of the systemic availability of the targeted substance.

️ Mechanistic Constraints

The drug's mechanism is constrained by the chemical properties of the ingested substance. The binding mechanism exhibits high affinity for non-polar, moderate-sized molecules but demonstrates low affinity or functional absence of binding for highly polar substances, small alcohols (e.g., ethanol), and certain inorganic salts (e.g., iron or lithium). These constraints define the physiological scope of the mechanism, as lack of binding results in no disruption of the absorption pathway.

Dosage and Administration Information

Tarmed, which contains Activated Charcoal, is an agent administered solely via the oral route in either aqueous suspension, liquid, or solid dosage forms. Its use is generally restricted to a supervised medical facility or under the direction of a health professional for acute situations. The pattern of use involves either a single, high dose or a short course of repeated doses, consistent with its role as an agent for emergency clinical management.

Standard Dosing and Frequency

The standard dose for adults in acute use is typically high, ranging from 25 g to 100 g, or may be calculated as 1 g per kilogram of estimated body weight. For regimens requiring repetition, an initial dose is followed by smaller, maintenance doses. These multiple-dose schedules are often administered at defined intervals, such as 25 g every 2 hours or 50 g every 4 hours.

Timing and Preparation Constraints

Administration must occur on an empty stomach and requires strict time separation from other oral intake. Standard administration involves a minimum gap of at least one hour before or two hours after food consumption. This separation rule also applies to other oral medications, which must be taken at least two hours apart to prevent Tarmed from reducing the concurrent drug's intended systemic effect. Suspensions must be shaken vigorously immediately before use to ensure uniform delivery of the fine particles.

Age-Specific Administration

Dosing for pediatric patients (children under 12) is adjusted based on body weight, commonly 1 g to 2 g per kilogram. A specific administration constraint involves avoiding cathartic-containing formulations (such as those with sorbitol) in infants and young children, and limiting their use to only the first dose in any multiple-dose regimen.

Recent Clinical Evidence

Tarmed: Recent Clinical Evidence

Research on Tarmed (Activated Charcoal) has focused on two main areas: reducing the body's absorption of toxins after a single acute oral ingestion and accelerating the elimination of certain substances that recirculate in the digestive system.

Evidence for Toxin Absorption

Studies examined Tarmed's role in reducing the systemic exposure to ingested substances. Controlled trials with healthy volunteers and limited randomized patient trials explored this effect, measuring the amount of the substance available for bloodstream absorption. These findings describe patterns observed in the studies where the measured difference was often greater when Tarmed was administered within the first hour of ingestion. However, the evidence base for connecting this measured absorption pattern directly to definitive improvements in patient-oriented outcomes—such as survival rates or shorter hospital stays—in general poisoning cases evidence remains limited and findings were mixed.

Evidence for Enhanced Elimination

Highly focused research has also evaluated Tarmed for enhanced elimination in cases involving a small group of specific substances known to recirculate in the body. These studies, which often include case reports and small series, described measured findings of an accelerated clearance rate for these select substances following repeated Tarmed doses. This effect appears to apply only to substances with known recirculation pathways.

Limitations and Research Gaps

The overall evidence quality varies across studies. While the data related to the physical action in controlled environments is established, the research is challenged by a lack of large, randomized controlled trials focusing on hard clinical outcomes. Data for certain groups remain insufficient, including evidence for older adults and children. Long-term effects are not fully established, as most research focuses on episodes where symptoms become more noticeable during the acute, short-term hospitalization period.

Key Studies & References

  1. Activated charcoal - eEML (WHO Electronic Essential Medicines List)

Frequently Asked Questions (FAQ)

Common questions about Tarmed (FAQ)

Q: Is Tarmed a brand-name drug or is it available as a generic version?

The active ingredient in Tarmed is Activated Charcoal. This substance is a generic compound, and Tarmed is a product name under which it may be delivered. Official regulatory information lists the substance by its generic name.


Q: Is there an over-the-counter version of Tarmed available?

Activated Charcoal is generally available as an Over-The-Counter (OTC) product for various indications. However, the high-dose liquid or suspension form used for emergency gastrointestinal decontamination is often administered under healthcare supervision in a medical setting.


Q: Where can I find the official prescribing information or a Patient Information Leaflet for Tarmed?

Official labeling and information, which includes the Patient Information Leaflet, are generally accessible through government-run drug databases, such as DailyMed, which compile and distribute regulatory drug data.


Q: Does Tarmed have a black box warning from the FDA or equivalent agency?

Official regulatory documents, such as those from the U.S. Food and Drug Administration (FDA), do not list a Black Box Warning for Activated Charcoal products. The labeling does, however, emphasize serious safety considerations related to the method of administration.


Q: Is Tarmed considered a high-risk medication by regulatory agencies?

Official labeling notes that the most serious risk related to the use of Activated Charcoal is pulmonary aspiration (inhalation into the lungs), which can be severe. For this reason, the medicine is contraindicated (prohibited from use) in individuals who are not fully conscious or who have an unprotected airway.


Q: What is the risk of a serious allergic reaction to Tarmed, based on official data?

The product labeling lists allergic reactions as potential severe adverse reactions. Signs such as hives, swelling of the face or throat, or difficulty breathing are noted as potential severe adverse reactions in the labeling.


Q: Is it true that Tarmed can affect laboratory blood test results?

Official sources note that Activated Charcoal can interfere with certain medical diagnostic tests. This interference occurs because the product affects the absorption of various substances. For example, it is specifically mentioned to potentially lead to unreliable readings for the guaiac card test.


Q: Does Tarmed interact with common over-the-counter cold medicines?

Tarmed is documented to reduce the absorption of all other oral medicines. Official documents therefore indicate that Tarmed should be taken at least 1 to 2 hours apart from any other oral medication, including over-the-counter cold medicines.


Q: Is it safe to consume caffeine while taking Tarmed, based on official warnings?

Official warnings state that Tarmed can reduce the absorption of substances taken by mouth. To avoid this potential reduction in absorption, Tarmed is generally separated from all oral intake, including caffeine, by at least 1 to 2 hours.


Q: What herbal supplements are officially listed as having potential interactions with Tarmed?

Regulatory documents indicate that Tarmed interacts with all oral products, including any herbal supplements. To prevent the charcoal from reducing the absorption of the herbal supplement, separation of the doses by at least 1 to 2 hours is indicated.


Q: Are there known interactions between Tarmed and common vitamins?

Official information notes that Tarmed can bind to and reduce the systemic availability of vitamins and other nutrients taken by mouth. It is generally specified that Tarmed and vitamins should be taken at least 1 to 2 hours apart to help prevent reduced absorption.


Q: Is it mentioned in the official labeling that Tarmed interacts with birth control pills?

Yes, regulatory information notes that Tarmed can reduce the effectiveness of oral contraceptive pills because it interferes with their absorption. Separation of the doses by several hours (e.g., 3 hours after or 12 hours before) may be indicated to help avoid this potential reduction.

How should Tarmed be stored and disposed of?

How to Store and Dispose of Tarmed (Activated Charcoal)

The storage and disposal of Tarmed must adhere strictly to the conditions specified in official regulatory labeling to ensure product integrity and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (typically 20-25 C or 68-77 F). Avoid excessive heat.
Protection Protect from moisture and store in a well-closed container. Suspension formulations should not be refrigerated.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Tarmed must be disposed of according to official regulatory guidance. The preferred method is using a drug take-back program. If this is unavailable, the product should be mixed with an undesirable substance (e.g., dirt or cat litter), placed into a sealed container, and discarded in the household trash. The product must not be flushed down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tarmed found in:

A-Z Index: